PC cells, however, acquire the ability to express neurotrophins as they progress and prostatic stromal cells from PC patients release in tumor microenvironment appreciable levels (from 827 to 2027 pg/106/48h) of neurotrophins [69,70]. Here, BDNF is linked to pachyonychia congenita.